A Pilot Study Examining Thiamine Deficiency in Patients Admitted to the Hospital for Liver Transplantation


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Jacksonville, Florida: 18-010361
    Sponsor Protocol Number: 18-010361

About this study

The purpose of this study is to report the proportion of thiamine deficiency (as defined by the Mayo Clinic Laboratory reference range) in liver transplant patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Adult patients, 18+ years old.
  • Patients with end stage liver disease of any etiology with an active offer for liver transplantation.

Exclusion Criteria: 

  • Prior transplant of any organ within the preceding 24 months.
  • Vulnerable populations (prisoners, pregnant women, patients <18 years old).

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Edward Blair, APRN

Open for enrollment

Contact information:

Carolyne Stevens



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer